RecruitingNot ApplicableNCT07424742

Graftless TSFE Via Self-tapping Implants

Transcrestal Graftless Schneiderian Membrane Elevation by Self-tapping Dental Implant


Sponsor

Sana'a University

Enrollment

20 participants

Start Date

Sep 9, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This prospective clinical trial aims to evaluate the efficiency, safety, and reliability of a minimally invasive graftless transcrestal sinus lifting approach with simultaneous dental implant placement in patients with edentulous posterior maxilla and limited residual bone height. The study investigates bone formation beneath the Schneiderian membrane, implant stability, osseointegration, and long-term implant survival.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Graftless Transcrestal Sinus Membrane Elevation with Simultaneous Implant Placement for people with alveolar bone atrophy, edentulous posterior maxilla, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREGraftless Transcrestal Sinus Membrane Elevation with Simultaneous Implant Placement

A minimally invasive transcrestal approach for sinus membrane elevation without graft material, followed by simultaneous placement of a 10 mm length and 4-4.5 mm diameter dental implant in the posterior maxilla with residual bone height of approximately 5 mm.


Locations(1)

Department of Oral and Maxillofacial Surgery, Sana'a University

Sanaa, Sanaa Governorate, Yemen

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07424742


Related Trials